TARRYTOWN, N.Y., Oct. 19, 2017 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that
Science magazine has once again ranked the company as the
world's number one employer in its annual survey of the biotech and
pharmaceutical industry. Regeneron has been ranked first for five
of the past seven years, with second place rankings in 2015 and
2011, making the company the most highly ranked over the past
decade.
"Our continued placement atop the Science Top Employers
list is a reflection of our passionate colleagues who dedicate
themselves each day to ground-breaking science that leads to
life-changing medicines," said George D.
Yancopoulos, M.D., Ph.D., President and Chief Scientific
Officer of Regeneron. "Maintaining our culture of innovation and
collaboration has been a key priority as we continue to grow beyond
6,000 people, explore new areas of research and help more
patients."
The Science and Science Careers' 2017 annual Top
Employers Survey polled employees in the biotechnology,
biopharmaceutical, pharmaceutical and related industries to
determine the best employers in these industries, as well as their
driving characteristics. Survey respondents rated Regeneron highly
based on 23 characteristics, including financial strength, easy
adaptation to change and a research-driven environment. Employees
rated Regeneron highest when it came to having a clear vision for
the future, being socially responsible and treating colleagues with
respect.
"Regeneron is proud to once again be recognized as the world's
number one employer in our industry," said Leonard S. Schleifer, M.D., Ph.D., President and
Chief Executive Officer of Regeneron. "We also strive to be the
best at bringing important new medicines to patients with
unmet medical needs. That means having the best science, people and
ethical standards, and creating an environment that rewards
innovation and enables people to do their very best work."
According to Science, the 2017 global survey results were
based on nearly 7,000 responses from North America (65 percent), Europe (25 percent) and the Asia/Pacific Rim (7 percent).
For the complete feature including individual company rankings,
please visit www.sciencecareers.org/TopEmployers2017.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading
biotechnology company that invents life-transforming medicines for
people with serious diseases. Founded and led for nearly 30 years
by physician-scientists, our unique ability to repeatedly and
consistently translate science into medicine has led to six
FDA-approved treatments and over a dozen product candidates in
development, all of which were homegrown in our laboratories. Our
medicines and pipeline are designed to help patients with eye
disease, heart disease, allergic and inflammatory diseases, pain,
cancer, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through our proprietary
VelociSuite® technologies, including
VelocImmune® to yield optimized fully-human
antibodies, and ambitious initiatives such as the Regeneron
Genetics Center, one of the largest genetics sequencing efforts in
the world. For additional information about the company, please
visit www.regeneron.com or follow @Regeneron on Twitter.
Regeneron Media Relations
Alexandra Bowie
Tel: +1
(914) 847-3407
alexandra.bowie@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/science-magazine-ranks-regeneron-1-biopharma-employer-for-fifth-time-300540067.html
SOURCE Regeneron Pharmaceuticals, Inc.